Thyroid cancer trials in Singapore
4 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in SingaporeSacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
- Where
- Singapore
- Age
- 18 years to 99 years
- People
- 68 worldwide
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT07521670 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Singapore
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - Phase 2Taking peopleSacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
- Where
- Singapore
- Age
- 21 years and over
- People
- 32
- Run by
- National University Hospital, Singapore
See details and how to joinNCT06923826 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Singapore
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00